Search Results - "Farnault, Laure"

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines by Alexandre, Joachim, Cautela, Jennifer, Ederhy, Stéphane, Damaj, Ghandi Laurent, Salem, Joe-Elie, Barlesi, Fabrice, Farnault, Laure, Charbonnier, Aude, Mirabel, Mariana, Champiat, Stéphane, Cohen-Solal, Alain, Cohen, Ariel, Dolladille, Charles, Thuny, Franck

“…The considerable progress made in the field of cancer treatment has led to a dramatic improvement in the prognosis of patients with cancer. However, toxicities…”
Get full text

Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue by Arcani, Robin, Colle, Julien, Cauchois, Raphaël, Koubi, Marie, Jarrot, Pierre-André, Jean, Rodolphe, Boyer, Arthur, Lachamp, Julie, Tichadou, Antoine, Couderc, Anne-Laure, Farnault, Laure, Costello, Regis, Venton, Geoffroy, Kaplanski, Gilles

“…Specificities of COVID-19 disease course in patients with haematologic malignancies are still poorly studied. So, we aimed to compare patients with…”
Get full text

The contribution of single-cell analysis of acute leukemia in the therapeutic strategy by Madaci, Lamia, Colle, Julien, Venton, Geoffroy, Farnault, Laure, Loriod, Béatrice, Costello, Régis

“…Abstract After decades during which the treatment of acute myeloblastic leukemia was limited to variations around a skeleton of cytarabine/anthracycline,…”
Get full text

High incidence of atrial fibrillation in patients treated with ibrutinib by Baptiste, Florian, Cautela, Jennifer, Ancedy, Yan, Resseguier, Noémie, Aurran, Thérèse, Farnault, Laure, Escudier, Marion, Ammar, Chloé, Gaubert, Mélanie, Dolladille, Charles, Barraud, Jeremie, Peyrol, Michael, Cohen, Ariel, Paganelli, Franck, Alexandre, Joachim, Ederhy, Stephane, Thuny, Franck

“…ObjectiveAtrial fibrillation (AF) is one of the most common side effects of ibrutinib, a drug that has dramatically improved the prognosis of chronic B-cell…”
Get full text

Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient by Solignac, Justine, Farnault, Laure, Robert, Thomas, Fanciullino, Raphaelle, Choquet, Sylvain, Brunet, Philippe, Venton, Geoffroy, Bobot, Mickaël

“…High dose methotrexate (HD-MTX) based chemoimmunotherapy is a central part of the standard approach to treatment of primary central nervous system lymphoma…”
Get full text

A transcriptomic signature predicting septic outcome in patients undergoing autologous stem cell transplantation by Labiad, Yasmine, Ventona, Geoffroy, Farnault, Laure, Baier, Céline, Colle, Julien, Mercier, Cédric, Ivanov, Vadim, Nicolino, Corinne, Loriod, Béatrice, Fernandez-Nunez, Nicolas, Torres, Magali, Mattei, Jean-Camille, Rihet, Pascal, Nguyen, Catherine, Costello, Régis

“…•A transcriptomic signature predicts infection in neutropenic patients.•The expression of 11 genes can be used routinely for sepsis prediction.•Early…”
Get full text

Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1 -Negative Myeloproliferative Neoplasm by Abbou, Norman, Piazzola, Pauline, Gabert, Jean, Ernest, Vincent, Arcani, Robin, Couderc, Anne-Laure, Tichadou, Antoine, Roche, Pauline, Farnault, Laure, Colle, Julien, Ouafik, L'houcine, Morange, Pierre, Costello, Régis, Venton, Geoffroy

“…-negative myeloproliferative neoplasms (MPNs) include three major subgroups-polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis…”
Get full text

Hematological Malignancies Escape from NK Cell Innate Immune Surveillance : Mechanisms and Therapeutic Implications by Farnault, Laure, Sanchez, Carole, Baier, Céline, Le Treut, Thérèse, Costello, Régis T.

“…Hematological malignancies treatment improved over the last years resulting in increased achievement of complete or partial remission, but unfortunately high…”
Get full text

CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine by Fanciullino, Raphaelle, Farnault, Laure, Donnette, Mélanie, Imbs, Diane-Charlotte, Roche, Catherine, Venton, Geoffroy, Berda-Haddad, Yael, Ivanov, Vadim, Ciccolini, Joseph, Ouafik, L'Houcine, Lacarelle, Bruno, Costello, Regis

“…Cytarabine (Ara-C) is the backbone of acute myeloid leukemia (AML) chemotherapy. Little is known about possible risk factors predictive for the frequent (ie,…”
Get full text

Persistence of natural killer cells with expansion of a hypofunctional CD56− CD16+ KIR+ NKG2C+ subset in a patient with atypical Janus kinase 3–deficient severe combined immunodeficiency by Farnault, Laure, MD, Chambost, Hervé, MD, Michel, Gérard, MD, Thuret, Isabelle, MD, de Saint Basile, Geneviève, MD, Fischer, Alain, MD, PhD, Picard, Capucine, MD, PhD, Picard, Christophe, MD, Orlanducci, Florence, Farnarier, Catherine, MD, Moretta, Alessandro, MD, PhD, Olive, Daniel, MD, PhD

“…[...]little is known about the mechanisms by which homozygous JAK3 R117C missense mutations impair JAK3 signaling in lymphocyte ontogeny to result in the…”
Get full text

Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients by Donnette, Melanie, Hamimed, Mourad, Ciccolini, Joseph, Sicard, Guillaume, Correard, Florian, Farnault, Laure, Ouafik, L'Houcine, Venton, Geoffroy, Fanciullino, Raphaëlle

“…Summary Azacitidine (Aza) is a mainstay of treatment for patients with acute myeloid leukaemia (AML) ineligible for induction chemotherapy and other high‐risk…”
Get full text

Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms by Madaci, Lamia, Farnault, Laure, Abbou, Norman, Gabert, Jean, Venton, Geoffroy, Costello, Régis

“…For decades, the diagnosis, prognosis and thus, the treatment of acute myeloblastic leukemias and myelodysplastic neoplasms has been mainly based on…”
Get full text

Pharmacokinetics/pharmacodynamics of liposomal cytarabine (VYXEOS) in AML patients: Influence of cytidine deaminase genetic polymorphisms by Donnette, Mélanie, Venton, Geoffroy, Farnault, Laure, Pourroy, Bertrand, Costello, Regis, Lacarelle, Bruno, Ouafik, L'Houcine, Ciccolini, Joseph, Fanciullino, Raphaëlle

“…Abstract only e19517 Background: Vyxeos is a liposomal formulation of daunorubicin and cytarabine recently approved for treating adults with newly-diagnosed…”
Get full text

Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy by Guérémy, Alexandre, Boucraut, José, Boudjarane, John, Grapperon, Aude-Marie, Fortanier, Etienne, Farnault, Laure, Gabert, Jean, Vely, Frédéric, Lacroix, Romaric, Kouton, Ludivine, Attarian, Shahram, Delmont, Emilien

“…Introduction Anti-MAG neuropathies are associated with an IgM monoclonal gammopathy of undetermined significance (MGUS) or with a malignant haemopathy. Our…”
Get full text

Faut-il prescrire des cures de consolidation aux patients avec indication d’allogreffe en première rémission complète d’une leucémie aiguë myéloïde ? by farnault, Laure

Get full text

Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study by Kim, Rathana, Chalandon, Yves, Rousselot, Philippe, Cayuela, Jean-Michel, Huguet, Françoise, Balsat, Marie, Passet, Marie, Chevallier, Patrice, Hicheri, Yosr, Raffoux, Emmanuel, Leguay, Thibaut, Chantepie, Sylvain, Maury, Sébastien, Hayette, Sandrine, Solly, Françoise, Braun, Thorsten, De Prijck, Bernard, Cacheux, Victoria, Salanoubat, Celia, Farnault, Laure, Guibaud, Isabelle, Lamarque, Mathilde, Gastaud, Lauris, Lemasle, Emilie, Brissot, Eolia, Tavernier, Emmanuelle, Bilger, Karine, Villate, Alban, Soulier, Jean, Graux, Carlos, Lhéritier, Véronique, Dombret, Hervé, Boissel, Nicolas, Clappier, Emmanuelle

“…quantification is widely regarded as the standard for monitoring measurable residual disease (MRD) in Philadelphia chromosome-positive (Ph+) ALL. However,…”
Get full text

Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351 by Donnette, Mélanie, Hamimed, Mourad, Ciccolini, Joseph, Berda-Haddad, Yael, Kaspi, Elise, Venton, Geoffroy, Lacarelle, Bruno, Costello, Regis, Ouafik, L'’Houcine, Farnault, Laure, Fanciullino, Raphaelle

“…CPX-351 is a liposome encapsulating cytarabine and daunorubicin for treating Acute Myeloid Leukemia (AML) patients. To what extent differences in cytidine…”
Get full text

Determination of 5-azacitidine in human plasma by LC–MS/MS: application to pharmacokinetics pilot study in MDS/AML patients by Donnette, Melanie, Osanno, Loic, Giocanti, Madeleine, Venton, Geoffroy, Farnault, Laure, Berda-Haddad, Yael, Costello, Régis, Caroline, Solas, Ouafik, L.’Houcine, Ciccolini, Joseph, Fanciullino, Raphaëlle

“…Purpose Azacitidine (Vidaza®, AZA) is a mainstay for treating acute myeloid leukemia (AML) in patients unfit for standard induction and other myelodysplastic…”
Get full text

Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100mg/m2 seems sufficient by Solignac, Justine, Farnault, Laure, Robert, Thomas, Fanciullino, Raphaelle, Choquet, Sylvain, Brunet, Philippe, Venton, Geoffroy, Bobot, Mickaël

“…High dose methotrexate (HD-MTX) based chemoimmunotherapy is a central part of the standard approach to treatment of primary central nervous system lymphoma…”
Get full text

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy by Berton, Guillaume, Arcani, Robin, Tichadou, Antoine, Farnault, Laure, Roche, Pauline, Colle, Julien, Ivanov, Vadim, Mercier, Cédric, Couderc, Anne-Laure, Costello, Regis, Taïeb, David, Venton, Geoffroy

Get full text